10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒      QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2015

☐      TRANSITION REPORT UNDER SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM __________ TO __________

COMMISSION FILE NUMBER: 000-54437

HYPERSOLAR, INC.

(Name of registrant in its charter)

Nevada	26-4298300
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

32 East Micheltorena, Suite A, Santa Barbara, CA 93101

(Address of principal executive offices) (Zip Code)

Issuer’s telephone Number: (805) 966-6566

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  ☒   No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐    No  ☒

The number of shares of registrant’s common stock outstanding, as of November 5, 2015 was 510,893,000.

HYPERSOLAR, INC.

INDEX

PART I: FINANCIAL INFORMATION
ITEM 1:	FINANCIAL STATEMENTS (Unaudited)	3
	Condensed Balance Sheets	3
	Condensed Statements of Operations	4
	Condensed Statement of Shareholders' Deficit	5
	Condensed Statements of Cash Flows	6
	Notes to the Condensed Financial Statements	7
ITEM 2:	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	11
ITEM 3:	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	14
ITEM 4:	CONTROLS AND PROCEDURES	15
PART II: OTHER INFORMATION
ITEM 1	LEGAL PROCEEDINGS	15
ITEM 1A:	RISK FACTORS	15
ITEM 2	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	15
ITEM 3	DEFAULTS UPON SENIOR SECURITIES	15
ITEM 4	MINE SAFETY DISCLOSURES	15
ITEM 5	OTHER INFORMATION	15
ITEM 6:	EXHIBITS	15
SIGNATURES		16

2

PART I   – FINANCIAL INFORMATION  

ITEM 1. FINANCIAL STATEMENTS

HYPERSOLAR, INC.
BALANCE SHEETS

	September 30, 2015			June 30, 2015
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash	$	70,416		$	39,491
TOTAL CURRENT ASSETS		70,416			39,491
PROPERTY & EQUIPMENT
Computers and peripherals		6,218			6,218
Less: accumulated depreciation		(5,553	)		(5,385	)
NET PROPERTY AND EQUIPMENT		665			833
OTHER ASSETS
Deposits		1,450			1,450
Domain, net of amortization $2,540 and $2,451, respectively		2,775			2,864
Patents		32,736			32,736
TOTAL OTHER ASSETS		36,961			37,050
TOTAL ASSETS	$	108,042		$	77,374
LIABILITIES AND SHAREHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts payable	$	122,193		$	97,467
Accrued expenses		300,227			279,419
Derivative liability		10,803,002			13,034,374
Convertible promissory notes, net of debt discount of $260,169 and $264,196, respectively		830,331			700,804
TOTAL CURRENT LIABILITIES		12,055,753			14,112,064
SHAREHOLDERS' DEFICIT
Preferred Stock, $0.001 par value; 5,000,000 authorized preferred shares, no shares issued or outstanding		-			-
Common Stock, $0.001 par value; 1,500,000,000 authorized common shares 493,839,853 and 476,848,072 shares issued and outstanding, respectively		493,840			476,848
Additional Paid in Capital		5,581,047			5,568,303
Accumulated deficit		(18,022,598	)		(20,079,841	)
TOTAL SHAREHOLDERS' DEFICIT		(11,947,711	)		(14,034,690	)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$	108,042		$	77,374

The accompanying notes are an integral part of these condensed financial statements

3

HYPERSOLAR, INC.
STATEMENTS OF OPERATIONS

	For the Three Months Ended
	September 30, 2015			September 30, 2014
REVENUE	$	-		$	-
OPERATING EXPENSES
General and administrative expenses		121,997			116,974
Research and development cost		21,735			-
Depreciation and amortization		257			339
TOTAL OPERATING EXPENSES		143,989			117,313
LOSS FROM OPERATIONS BEFORE  OTHER INCOME (EXPENSES)		(143,989	)		(117,313	)
OTHER INCOME/(EXPENSES)
Gain on forgiveness of debt		-			-
Net Gain/(Loss) on change in derivative liability		2,381,372			2,853,054
Interest expense		(180,140	)		(126,486	)
TOTAL OTHER INCOME/(EXPENSES)		2,201,232			2,726,568
NET INCOME	$	2,057,243		$	2,609,255
BASIC AND DILUTED LOSS PER SHARE	$	0.00		$	0.01
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING
BASIC AND DILUTED		477,217,459			443,550,158

The accompanying notes are an integral part of these condensed financial statements

4

HYPERSOLAR, INC.
STATEMENTS OF SHAREHOLDERS' DEFICIT
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2015

									Additional
	Preferred stock				Common stock				Paid-in		Accumulated
	Shares		Amount		Shares		Amount		Capital		Deficit			Total
Balance at June 30, 2015		-		-		476,848,072		476,848		5,568,303		(20,079,841	)		(14,034,690	)
Issuance of common stock for conversion of debt		-		-		16,991,781		16,992		12,744		-			29,736
Net income for the three months ended September 30, 2015		-		-		-		-		-		2,057,243			2,057,243
Balance at September 30, 2015 (unaudited)		-	$	-		493,839,853	$	493,840	$	5,581,047	$	(18,022,598	)	$	(11,947,711	)

The accompanying notes are an integral part of these condensed financial statements

5

HYPERSOLAR, INC.
STATEMENTS OF CASH FLOWS

	Three Months Ended
	September 30, 2015			September 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	2,057,243		$	2,609,255
Adjustment to reconcile net income to net cash used in operating activities
Depreciation & amortization expense		257			339
Loss on change in derivative liability		(2,381,372	)		(2,853,054	)
Amortization of debt discount and beneficial conversion feature recorded as interest expense		154,027			112,467
Change in Assets and Liabilities:
(Increase) Decrease in:
Deposits		-			(525	)
Increase (Decrease) in:
Accounts payable		24,726			1,837
Accrued expenses		26,044			13,886
NET CASH USED IN OPERATING ACTIVITIES		(119,075	)		(115,795	)
NET CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of intangible assets		-			(2,000	)
NET CASH USED IN INVESTING ACTIVITIES		-			(2,000	)
NET CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes payable		150,000			100,000
NET CASH PROVIDED BY FINANCING ACTIVITIES		150,000			100,000
NET (DECREASE)/INCREASE IN CASH		30,925			(17,795	)
CASH, BEGINNING OF PERIOD		39,491			61,628
CASH, END OF PERIOD	$	70,416		$	43,833
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$	70		$	134
Taxes paid	$	-		$	-
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Issuance of common stock upon conversion of convertible notes	$	29,736		$	33,625

The accompanying notes are an integral part of these condensed financial statements

6

HYPERSOLAR, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2015

1. BASIS OF PRESENTATION

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending June 30, 2016. For further information refer to the financial statements and footnotes thereto included in the Company's Form 10-K for the year ended June 30, 2015.

Going Concern

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has historically obtained funds through private placement offerings of equity and debt. Management believes that it will be able to continue to raise funds by sale of its securities to its existing shareholders and prospective new investors to provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business. There is no assurance that the Company will be able to continue raising the required capital.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

This summary of significant accounting policies of HyperSolar, Inc. is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Cash and Cash Equivalent

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of intangible assets, and the deferred tax valuation allowance. Actual results could differ from those estimates.

Intangible Assets

Intangible assets consist of patents that are initially measured at the lower of cost or fair value. The patents are deemed to have an indefinite life and are not amortized. The patents are assessed annually for impairment, or whenever conditions indicate the asset may be impaired, and any such impairment will be recognized in the period identified.

Loss per Share Calculations

Loss per Share dictates the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. No shares for the convertible notes were used in the calculation of the loss per share as they were all anti-dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the three months ended September 30, 2015, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company excluded 500,000 of options, and the shares issuable from convertible debt of $1,090,500 for the three months ended September 30, 2015.

Stock based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

7

HYPERSOLAR, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2015

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Fair Value of Financial Instruments

Fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2015, the amounts reported for cash, accrued interest and other expenses, notes payables, and derivative liability approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2015:

	Total		(Level 1)		(Level 2)		(Level 3)
Liabilities
Derivative liability		10,803,002		-		-		10,803,002
Total liabilities measured at fair value	$	10,803,002	$	-	$	-	$	10,803,002

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

Beginning balance as of July 1, 2015	$	13,034,374
Fair value of derivative liabilities issued		256,970
Gain on change in derivative liability		(2,488,342	)
Ending balance as of September 30, 2015	$	10,803,002

Accounting for Derivatives

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Black-Scholes-Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Recently issued pronouncements

On August 27, 2014, the Company adopted the amendment to ASU 2014-15 on Presentation of Financial Statements Going Concern (Subtopic 205-40). The amendment provides for guidance to reduce diversity in the timing and content of footnote disclosures. The amendment requires management to assess the Company’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The Company has to define the term of substantial doubt, which has to be evaluated every reporting period including interim periods. Management has to provide principles for considering the mitigating effect of its plan, and disclose when substantial doubt is alleviated as well as when it is not alleviated. The Company is required to assess managements plan for a period of one year after the financial statements are issued (or available to be issued). The amendment is effective for annual periods ending after December 15, 2016. Early adoption is permitted. The Company does not believe the accounting standards currently adopted will have a material effect on the accompanying condensed financial statements.

8

HYPERSOLAR, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2015

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

3. CAPITAL STOCK

During the three months ended September 30, 2015, the Company issued 16,991,781 shares of common stock upon conversion of $24,500 in principal, plus $5,236 in accrued interest on an outstanding convertible note.

4. STOCK OPTIONS

Options

On March 31, 2015, the Company granted 250,000 non-qualified stock options to an employee. As of March 31, 2015, 500,000 non-qualified common stock options were outstanding. Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective agreements may provide. Each Option expires on the date specified in the Option agreement, which date is not later than the fifth (5^th) anniversary from the grant date of the options. As of September 30, 2015, 250,000 options are fully vested and are exercisable at an exercise price $0.04 per share. The 250,000 stock options granted on March 31, 2015 are not currently exercisable and are subject to vesting conditions which provide that fifty (50%) percent of the options vest on March 31, 2016 and the remaining fifty (50%) on March 31, 2017. These stock options are exercisable for a period of five years from the date of grant at an exercise price of $0.02245 per share.

A summary of the Company’s stock option activity and related information follows:

	9/30/2015
			Weighted
	Number		average
	of		exercise
	Options		price
Outstanding, beginning of period		500,000	$	0.03
Granted		-		-
Exercised		-		-
Forfeited/Expired		-		-
Outstanding, end of period		500,000	$	0.03
Exercisable at the end of period		250,000	$	0.04
Weighted average fair value of options granted during the period			$	-

5. CONVERTIBLE PROMISSORY NOTES

On August 9, 2013, the Company entered into a securities purchase agreement entered into for the sale of a 10% convertible promissory note in the aggregate principal amount of up to $100,000. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of a) $0.0048 per share; b) fifty percent (50%) of the lowest trading price after the effective date of each respective advance or c) the lowest conversion price offered by the Company with respect to any financing occurring before or after the date to acquire common stock. Upon execution of the securities purchase agreement, the Company received an advance of $15,000. The Company received additional advances in the aggregate amount of $85,000 for a total aggregate principal sum of $100,000. The Note matured on July 9, 2015, and the maturity date was extended to April 9, 2016. On September 28, 2015, the Company issued 16,991,781 shares of common stock upon conversion of $24,500 in principal, plus accrued interest of $5,236. The remaining balance as of September 30, 2015 was $75,500.

On December 16, 2013, the Company entered into a securities purchase agreement entered for the sale of a 10% convertible promissory note in the aggregate principal amount of up to $100,000. The Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.0048 per share or fifty percent (50%) of the lowest trading price after the effective date to acquire common stock. Upon execution of the securities purchase agreement, the Company received an advance of $26,000. The Company received additional advances in the amount of $74,000 for an aggregate sum of $100,000. The Note matured on May 16, 2015, and the maturity date was extended to February 16, 2016.

On March 5, 2014, the Company entered into a securities purchase agreement into for the sale of a 10% convertible promissory note in the aggregate principal amount of up to $100,000. The Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.0048 per share or fifty percent (50%) of the lowest trading price after the effective date to acquire common stock. Upon execution of the securities purchase agreement, the Company received an advance of $30,000. On April 15, 2014, the lender and borrower agreed to amend the note to increase the principle sum to $150,000. The Company received additional advances in the amount of $120,000 for an aggregate sum of $150,000. The Note matured on September 5, 2015 and was extended to June 5, 2016.

9

HYPERSOLAR, INC.

NOTES TO FINANCIAL STATEMENTS

SEPTEMBER 30, 2015

5. CONVERTIBLE PROMISSORY NOTES (Continued)

On May 23, 2014, the Company entered into a securities purchase agreement for the sale of a 10% convertible promissory note in the aggregate principal amount of up to $500,000. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.0048 per share or fifty percent (50%) of the lowest trading price after the effective date to acquire common stock. Upon execution of the securities purchase agreement, the Company received an advance of $50,000. The Company received additional advances in the amount of $415,000 for an aggregate sum of $465,000. The Note matured on May 23, 2015 and was extended to February 23, 2016. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $79,397 during the three months ended September 30, 2015.

On April 9, 2015, the Company entered into a securities purchase agreement into for the sale of a 10% convertible promissory note in the aggregate principal amount of up to $500,000. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective advance or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. Upon execution of the securities purchase agreement, the Company received an advance of $50,000. The Company received additional advances in the amount of $250,000 for an aggregate sum of $300,000. The note matures nine (9) months from the effective dates of each respective advance. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $74,630 during the three months ended September 30, 2015.

ASC Topic 815 provides guidance applicable to convertible debt issued by the Company in instances where the number into which the debt can be converted is not fixed. For example, when a convertible debt converts at a discount to market based on the stock price on the date of conversion, ASC Topic 815 requires that the embedded conversion option of the convertible debt be bifurcated from the host contract and recorded at their fair value. In accounting for derivatives under accounting standards, the Company recorded a liability representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount representing the imputed interest associated with the embedded derivative. The discount is amortized over the life of the convertible debt, and the derivative liability is adjusted periodically according to stock price fluctuations.

6. DERIVATIVE LIABILITIES

The convertible notes (the “Notes”) issued and described in Note 5 do not have fixed settlement provisions because their conversion prices are not fixed. The conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.

During the three months ended September 30, 2015, as a result of the Notes issued that were accounted for as derivative liabilities, we determined that the fair value of the conversion feature of the convertible notes at issuance was $256,970, based upon a Black-Sholes-Model calculation. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the Notes.

During the three months ended September 30, 2015, approximately $24,500 in principal of the Notes were converted. As a result of the conversion of these Notes, and the change in fair value of the remaining Notes, the Company recorded a net gain in change in derivative of $2,488,342 in the statement of operations for the three months ended September 30, 2015. At September 30, 2015, the fair value of the derivative liability was $10,803,002.

For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivative are as follows:

Risk free interest rate	0.00% - 0.47%
Stock volatility factor	15.55% - 318.08%
Weighted average expected option life	1 month - 9 months
Expected dividend yield	None

7. SUBSEQUENT EVENTS

Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855, and reported the following events:

On October 1, 2015, the Company received an additional $50,000 advance on the securities purchase agreement entered into on April 9, 2015.

On October 14, 2015, the Company issued 17,053,151 shares of common stock upon conversion of $24,500 in principal, plus accrued interest of $5,343 associated with the securities purchase agreement entered into on August 9, 2013.

On October 21, 2015, the Company received an additional $60,000 advance on the securities purchase agreement entered into on April 9, 2015. 

10

ITEM 2:  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Statement Regarding Forward-Looking Statements

The information in this discussion may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties, including statements regarding our capital needs, business strategy and expectations. Any statements that are not of historical fact may be deemed to be forward-looking statements. These forward-looking statements involve substantial risks and uncertainties. In some cases you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue”, the negative of the terms or other comparable terminology. Actual events or results may differ materially from the anticipated results or other expectations expressed in the forward-looking statements. In evaluating these statements, you should consider various factors, including the risks included from time to time in other reports or registration statements filed with the United States Securities and Exchange Commission. These factors may cause our actual results to differ materially from any forward-looking statements. We disclaim any obligation to publicly update these statements, or disclose any difference between actual results and those reflected in these statements.

Unless the context otherwise requires, references in this Form 10-Q to “we,” “us,” “our,” or the “Company” refer to Hypersolar, Inc.

Overview

Inspired by the photosynthetic process that plants use to harness the power of the sun to create energy molecules, we are developing a novel solar-powered particle system that mimics photosynthesis to separate hydrogen from water.  On November 15, 2011, we filed a patent application to protect the intellectual property rights to the production of renewable hydrogen and natural gas using sunlight, water, and carbon dioxide.  

Our research is centered on developing a low-cost and submersible hydrogen production particle that can split water molecules under the sun, emulating the core functions of photosynthesis. Each particle is a complete hydrogen generator that contains a novel high voltage solar cell bonded to chemical catalysts by a proprietary encapsulation coating.  On September 15, 2015, we announced that we had surpassed the critical voltage (1.5 Volts) threshold to split water molecules for renewable hydrogen fuel production. We believe this is an extremely important step towards commercialization, as 1.5 V is the minimum voltage needed to produce hydrogen in real world systems.

Currently, the strategy of partnering with both the University of Iowa and University of California, Santa Barbara (“UCSB”), has advanced our technology significantly. In November of 2014, the University of Iowa was added to the research and development team, giving us the support of two leading universities as we continue our pursuit of commercially viable renewable hydrogen. On October 15, 2015, we extended the term of our agreement with the University of Iowa until April 30, 2016. As the technology progresses, the University of Iowa team will continue to focus on increasing the voltage of the technology, while the UCSB team will focus more on the technology’s production aspects and cost models for scaled up systems. We anticipate continuing this strategy of leveraging our existing relationship, as well as potentially exploring relationships with other leading universities, to continue developing our technology.

Now that we have surpassed the 1.5 V threshold required for hydrogen fuel production in real world systems, we will identify the next steps in terms of scaling up the technology. Following this breakthrough, we will focus our efforts on increasing the hydrogen production efficiencies of these particles by bonding the ideal fuel production catalyst to the low-cost, high-voltage solar cell. In order to achieve this, the Company is currently exploring two parallel approaches. The first is to identify materials that interface with well-known hydrogen production catalysts, such as the platinum on solar particles, to improve sunlight-to-hydrogen conversion efficiency. The second is to pursue methods that further increase photo voltages of solar particles to greater than 1.7 V that allow integration of cheaper earth abundant catalysts without significant loss in hydrogen production efficiency. We believe this will bring us closer to developing a prototype or pilot.

11

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to impairment of property, plant and equipment, intangible assets, deferred tax assets and fair value computation using the Black Scholes option pricing model. We base our estimates on historical experience and on various other assumptions, such as the trading value of our common stock and estimated future undiscounted cash flows, that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are reasonable.

Use of Estimates

In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to recording net revenue, collectability of accounts receivable, useful lives and impairment of tangible and intangible assets, accruals, income taxes, inventory realization, stock-based compensation expense, Black Scholes valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.

Fair Value of Financial Instruments

Fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2015, the amounts reported for cash, accrued interest and other expenses, notes payables, and derivative liability approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Recently Issued Accounting Pronouncements

In August 2014, FASB issued ASU 2014-15, “Presentation of Financial Statements Going Concern (Subtopic 205-40) –  Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern ”. Currently, there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this ASU provide that guidance. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term  substantial doubt,  (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this ASU are effective for public and nonpublic entities for annual periods ending after December 15, 2016. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2014-15 on the Company’s financial statements.

Management reviewed currently issued pronouncements during the nine months ended September 30, 2015, and does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

12

Results of Operations for the Three Months Ended September 30, 2015 compared to Three Months Ended September 30, 2014.

Operating Expenses

Operating expenses for the three months ended September 30, 2015 were $143,989 and $117,313 for the prior period ended September 30, 2014. The net increase of $26,676 in operating expenses consisted primarily of the research and development cost associated with outside consulting in the amount of $21,735, with an overall increase in general and administrative expenses of $4,941.

Other Income/(Expenses)

Other income and (expenses) for the three months ended September 30, 2015 were $2,201,232 and $2,726,568 for the prior period ended September 30, 2014. The decrease of $525,336 in other income and (expenses) was the result of a decrease in net gain on change in fair value of the derivative instruments of $471,682, with an increase in amortization of debt discount of $41,560, and interest expense of $12,094.

Net Income

For the three months ended September 30, 2015, our net income was $2,057,243 as compared to $2,609,255 for the prior period September 30, 2014. The decrease of $552,012in net income was related primarily to other income and (expenses) due to a decrease in non-cash cost associated with the fair value of the convertible notes. The Company has not generated any revenues.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.

As of September 30, 2015, we had a working capital deficit of $11,985,337 as compared to $14,072,573 as of June 30, 2015. This decrease in working capital deficit of $2,087,236 was due primarily to an increase in cash, accounts payable, accrued expenses, convertible notes, offset with a decrease in non-cash derivative liability.

Cash flow used in operating activities was $119,075 for the three months ended September 30, 2015 and $115,795 for the prior period ended September 30, 2014. The increase in cash used by operating activities was primarily due to an increase in accounts payable, accrued expenses, amortization of debt discount, with a decrease in deposits and non-cash loss on change in derivative liability. The Company has had no revenues.

Cash used in investing activities for the three months ended September 30, 2015 was $0, compared to $2,000 for the prior period ended September 30, 2014. The decrease in investing activities was due to the purchase of tangible assets in the prior period, compared to no purchases in the current period.

Cash provided by financing activities during the three months ended September 30, 2015 was $150,000 and $100,000 for the prior period ended September 30, 2014. The increase in financing activities was due to equity financing with convertible notes through private placements during the current period.

13

Our financial statements as of September 30, 2015 have been prepared under the assumption that we will continue as a going concern for the three months ended September 30, 2015. Liggett, Vogt, & Webb P.A., in their report dated September 23, 2015, on our financial statements, included an explanatory paragraph expressing substantial doubt in our ability to continue as a going concern without additional capital becoming available. Our ability to continue as a going concern ultimately is dependent on our ability to generate a profit which is dependent upon our ability to obtain additional equity or debt financing, attain further operating efficiencies and, ultimately, to achieve profitable operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The condensed financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying condensed financial statements do not reflect any adjustments that might result if we are unable to continue as a going concern. During the three months ended September 30, 2015, we did not generate any revenues, incurred net income of $2,057,243 and cash used in operations of $119,075. As of September 30, 2015, we had a working capital deficiency of $11,985,337 and a shareholders’ deficit of $11,947,711. These factors, among others raise substantial doubt about our ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended June 30, 2015 expressed substantial doubt about our ability to continue as a going concern. Our ability of us to continue as a going concern and suitability of using the going concern basis is dependent upon, among other things, additional cash infusion. We have obtained funds from our shareholders. In the three months ended September 30, 2015, we obtained funding through the sale of our securities. Management believes that we will be able to continue to raise funds through the sale of our securities to existing and new investors. Management believes that funding from existing and prospective new investors and future revenue will provide the additional cash needed to meet our obligations as they become due, and will allow the development of our core business operations.

PLAN OF OPERATION AND FINANCING NEEDS

Our plan of operation within the next twelve months is to further research, develop, and protect our technology.  We expect to incur additional expenses in prosecuting our primary patent.

Working with both the University of Iowa and University of California, Santa Barbara (“UCSB”), gives us the support of two leading universities as we continue our pursuit of commercially viable renewable hydrogen. As the technology progresses, the University of Iowa team will continue to focus on increasing the voltage of the technology, while the UCSB team will focus more on the technology’s production aspects and cost models for scaled up systems. We anticipate continuing this strategy of leveraging our existing relationship, as well as potentially exploring relationships with other leading universities, to continue developing our technology.

Off-Balance Sheet Arrangements

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues or expenses, result of operations, liquidity or capital expenditures.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not required for Smaller Reporting Companies.

14

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act). Based upon this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms, and (ii) accumulated and communicated to our management, including our chief executive officer and chief financial officer, or person performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There was no change to our internal control over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are not currently a party to, nor is any of our property currently the subject of, any pending legal proceeding that will have a material adverse effect on our business.

ITEM 1A. RISK FACTORS

There are no material changes from the risk factors previously disclosed in our annual report on Form 10-K filed with the SEC on September 28, 2015.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the three months ended September 30, 2015, the Company issued 16,991,781 shares of common stock upon conversion of $24,500 in principal, plus accrued interest of $5,236.

The Company relied on an exemption pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended in connection with the sale and issuances of its shares of common stock described above.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

ITEM 4. MINE SAFETY DISCLOSURES

No disclosure required.

ITEM 5. OTHER INFORMATION

None. 

ITEM 6. EXHIBITS

Exhibit No.	Description
10.1	Contract between Hypersolar, Inc. and the University of Iowa dated as of October 15, 2015 (filed herewith).
31.1	Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to Sarbanes-Oxley Section 302 (filed herewith).
32.2	Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to 18 U.S.C. Section 1350 (filed herewith).
EX-101.INS	XBRL Instance Document
EX-101.SCH	XBRL Taxonomy Extension Schema Document
EX-101.CAL	XBRL Taxonomy Extension Calculation Linkbase
EX-101.DEF	XBRL Taxonomy Extension Definition Linkbase
EX-101.LAB	XBRL Taxonomy Extension Labels Linkbase
EX-101.PRE	XBRL Taxonomy Extension Presentation Linkbase

15

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

November 6, 2015	HYPERSOLAR, INC.
	By:	/s/ Timothy Young
		Timothy Young Chief Executive Officer and Acting Chief Financial Officer (Principal Executive Officer and Principal Financial Officer and Accounting Officer)

16

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO

RULE 13a-14(a) OR RULE 15d-14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934

I, Timothy Young, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Hypersolar, Inc. for the quarter ended September 30, 2015;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

November 6, 2015 /s/ Timothy Young Timothy Young Chief Executive Officer Acting Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hypersolar, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy Young, Chief Executive Officer and Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

November 6, 2015	/s/ Timothy Young
	Timothy Young Chief Executive Officer Acting Chief Financial Officer

XML

Capital Stock

3 Months Ended

Sep. 30, 2015

Capital Stock [Abstract]

CAPITAL STOCK

3. CAPITAL STOCK

During the three months ended September 30, 2015, the Company issued 16,991,781 shares of common stock upon conversion of $24,500 in principal, plus $5,236 in accrued interest on an outstanding convertible note.

XML

Summary of Significant Accounting Policies

3 Months Ended

Sep. 30, 2015

Summary of Significant Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

This summary of significant accounting policies of HyperSolar, Inc. is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Cash and Cash Equivalent

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of intangible assets, and the deferred tax valuation allowance. Actual results could differ from those estimates.

Intangible Assets

Intangible assets consist of patents that are initially measured at the lower of cost or fair value. The patents are deemed to have an indefinite life and are not amortized. The patents are assessed annually for impairment, or whenever conditions indicate the asset may be impaired, and any such impairment will be recognized in the period identified.

Loss per Share Calculations

Loss per Share dictates the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. No shares for the convertible notes were used in the calculation of the loss per share as they were all anti-dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the three months ended September 30, 2015, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company excluded 500,000 of options, and the shares issuable from convertible debt of $1,090,500 for the three months ended September 30, 2015.

Stock based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

Fair Value of Financial Instruments

Fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2015, the amounts reported for cash, accrued interest and other expenses, notes payables, and derivative liability approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2015:

	Total		(Level 1)		(Level 2)		(Level 3)
Liabilities
Derivative liability		10,803,002		-		-		10,803,002
Total liabilities measured at fair value	$	10,803,002	$	-	$	-	$	10,803,002

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

Beginning balance as of July 1, 2015	$	13,034,374
Fair value of derivative liabilities issued		256,970
Gain on change in derivative liability		(2,488,342	)
Ending balance as of September 30, 2015	$	10,803,002

Accounting for Derivatives

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Black-Scholes-Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Recently issued pronouncements

On August 27, 2014, the Company adopted the amendment to ASU 2014-15 on Presentation of Financial Statements Going Concern (Subtopic 205-40). The amendment provides for guidance to reduce diversity in the timing and content of footnote disclosures. The amendment requires management to assess the Company’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The Company has to define the term of substantial doubt, which has to be evaluated every reporting period including interim periods. Management has to provide principles for considering the mitigating effect of its plan, and disclose when substantial doubt is alleviated as well as when it is not alleviated. The Company is required to assess managements plan for a period of one year after the financial statements are issued (or available to be issued). The amendment is effective for annual periods ending after December 15, 2016. Early adoption is permitted. The Company does not believe the accounting standards currently adopted will have a material effect on the accompanying condensed financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

XML

Balance Sheets - USD ($)	Sep. 30, 2015	Jun. 30, 2015
CURRENT ASSETS
Cash	$ 70,416	$ 39,491
TOTAL CURRENT ASSETS	70,416	39,491
PROPERTY & EQUIPMENT
Computers and peripherals	6,218	6,218
Less: accumulated depreciation	(5,553)	(5,385)
NET PROPERTY AND EQUIPMENT	665	833
OTHER ASSETS
Deposits	1,450	1,450
Domain, net of amortization $2,540 and $2,451, respectively	2,775	2,864
Patents	32,736	32,736
TOTAL OTHER ASSETS	36,961	37,050
TOTAL ASSETS	108,042	77,374
CURRENT LIABILITIES
Accounts payable	122,193	97,467
Accrued expenses	300,227	279,419
Derivative liability	10,803,002	13,034,374
Convertible promissory notes, net of debt discount of $260,169 and $264,196, respectively	830,331	700,804
TOTAL CURRENT LIABILITIES	$ 12,055,753	$ 14,112,064
SHAREHOLDERS' DEFICIT
Preferred Stock, $0.001 par value; 5,000,000 authorized preferred shares, no shares issued or outstanding
Common Stock, $0.001 par value; 1,500,000,000 authorized common shares 493,839,853 and 476,848,072 shares issued and outstanding, respectively	$ 493,840	$ 476,848
Additional Paid in Capital	5,581,047	5,568,303
Accumulated deficit	(18,022,598)	(20,079,841)
TOTAL SHAREHOLDERS' DEFICIT	(11,947,711)	(14,034,690)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 108,042	$ 77,374

XML

Statements of Cash Flows - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 2,057,243	$ 2,609,255
Adjustment to reconcile net income to net cash used in operating activities
Depreciation & amortization expense	257	339
Loss on change in derivative liability	(2,381,372)	(2,853,054)
Amortization of debt discount and beneficial conversion feature recorded as interest expense	$ 154,027	112,467
(Increase) Decrease in:
Deposits		(525)
Increase (Decrease) in:
Accounts payable	$ 24,726	1,837
Accrued expenses	26,044	13,886
NET CASH USED IN OPERATING ACTIVITIES	$ (119,075)	(115,795)
NET CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of intangible assets		(2,000)
NET CASH USED IN INVESTING ACTIVITIES		(2,000)
NET CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes payable	$ 150,000	100,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	150,000	100,000
NET (DECREASE)/INCREASE IN CASH	30,925	(17,795)
CASH, BEGINNING OF PERIOD	39,491	61,628
CASH, END OF PERIOD	70,416	43,833
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$ 70	$ 134
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Issuance of common stock upon conversion of convertible notes	$ 29,736	$ 33,625

XML

Stock Options (Details) - Stock options [Member]	3 Months Ended
	Sep. 30, 2015 $ / shares shares
Number of Options
Outstanding, beginning of period | shares	500,000
Granted | shares
Exercised | shares
Forfeited/Expired | shares
Outstanding, end of period | shares	500,000
Exercisable at the end of period | shares	250,000
Weighted average exercise price
Outstanding, beginning of period	$ 0.03
Granted
Exercised
Forfeited/Expired
Outstanding, end of period	$ 0.03
Exercisable at the end of period	$ 0.04
Weighted average fair value of options granted during the period

XML

Convertible Promissory Notes (Details) - USD ($)						1 Months Ended	3 Months Ended
	Apr. 09, 2015	May. 23, 2014	Mar. 05, 2014	Dec. 16, 2013	Aug. 09, 2013	Sep. 28, 2015	Sep. 30, 2015
Convertible Promissory Notes (Textual)
Principal amount of partial convertible promissory note							$ 1,090,500
Convertible promissory note [Member] | Securities Purchase Agreements [Member] | 10% Convertible Promissory Notes [Member]
Convertible Promissory Notes (Textual)
Amount received in consideration of sale of debt					$ 15,000
Convertible promissory notes, interest rate					10.00%
Amount of additional advance received					$ 85,000
Convertible promissory note principal amount					100,000
Cumulative outstanding principal amount					$ 100,000
Issuance of common stock on payment of accrued interest for convertible notes						$ 5,236
Conversion price					$ 0.0048
Percentage of trading price					50.00%
Debt instrument, Maturity date description					The Note matured on July 9, 2015, and the maturity date was extended to April 9, 2016.
Maturity date					Jul. 09, 2016
Debt instrument, convertible, terms of conversion feature					Price equal to a variable conversion price of the lesser of a) $0.0048 per share; b) fifty percent (50%) of the lowest trading price after the effective date of each respective advance or c) the lowest conversion price offered by the Company with respect to any financing occurring before or after the date to acquire common stock.
Convertible debt remains balance							75,500
Issuance of common stock (in shares)						16,991,781
Principal amount of partial convertible promissory note						$ 24,500
Convertible Promissory Notes One [Member] | Securities Purchase Agreements [Member] | 10% Convertible Promissory Notes [Member]
Convertible Promissory Notes (Textual)
Amount received in consideration of sale of debt				$ 26,000
Convertible promissory notes, interest rate				10.00%
Amount of additional advance received				$ 74,000
Convertible promissory note principal amount				100,000
Cumulative outstanding principal amount				$ 100,000
Conversion price				$ 0.0048
Percentage of trading price				50.00%
Debt instrument, Maturity date description				The Note matured on May 16, 2015, and the maturity date was extended to February 16, 2016.
Maturity date				May 16, 2015
Debt instrument, convertible, terms of conversion feature				Price equal to a variable conversion price of the lesser of $0.0048 per share or fifty percent (50%) of the lowest trading price after the effective date to acquire common stock.
Convertible Promissory Notes Two [Member] | Securities Purchase Agreements [Member] | 10% Convertible Promissory Notes [Member]
Convertible Promissory Notes (Textual)
Amount received in consideration of sale of debt			$ 30,000
Convertible promissory notes, interest rate			10.00%
Amount of additional advance received			$ 120,000
Convertible promissory note principal amount			150,000
Cumulative outstanding principal amount			$ 100,000
Conversion price			$ 0.0048
Percentage of trading price			50.00%
Debt instrument, Maturity date description			The Note matured on September 5, 2015 and was extended to June 5, 2016.
Maturity date			Sep. 05, 2016
Debt instrument, convertible, terms of conversion feature			Price of the lesser of $0.0048 per share or fifty percent (50%) of the lowest trading price after the effective date to acquire common stock.
Debt instrument, increase (decrease), Net			$ 150,000
Convertible Promissory Notes Three [Member] | Securities Purchase Agreements [Member] | 10% Convertible Promissory Notes [Member]
Convertible Promissory Notes (Textual)
Amount received in consideration of sale of debt		$ 50,000
Convertible promissory notes, interest rate		10.00%
Interest expense							79,397
Amount of additional advance received		$ 415,000
Convertible promissory note principal amount		465,000
Cumulative outstanding principal amount		$ 500,000
Conversion price		$ 0.0048
Percentage of trading price		50.00%
Debt instrument, Maturity date description		The note matured on May 23, 2015 and was extended to February 23, 2016.
Maturity date		May 23, 2015
Debt instrument, convertible, terms of conversion feature		Price equal to a variable conversion price of the lesser of $0.0048 per share or fifty percent (50%) of the lowest trading price after the effective date to acquire common stock.
Convertible Promissory Notes Four [Member] | Securities Purchase Agreements [Member] | 10% Convertible Promissory Notes [Member]
Convertible Promissory Notes (Textual)
Amount received in consideration of sale of debt	$ 50,000
Convertible promissory notes, interest rate	10.00%
Interest expense							$ 74,630
Amount of additional advance received	$ 250,000
Convertible promissory note principal amount	300,000
Cumulative outstanding principal amount	$ 500,000
Conversion price	$ 0.01
Percentage of trading price	50.00%
Debt instrument, term	9 months
Debt instrument, convertible, terms of conversion feature	Price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective advance or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock.

XML

Basis of Presentation

3 Months Ended

Sep. 30, 2015

Basis of Presentation [Abstract]

BASIS OF PRESENTATION

1. BASIS OF PRESENTATION

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending June 30, 2016. For further information refer to the financial statements and footnotes thereto included in the Company's Form 10-K for the year ended June 30, 2015.

Going Concern

The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company does not generate revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has historically obtained funds through private placement offerings of equity and debt. Management believes that it will be able to continue to raise funds by sale of its securities to its existing shareholders and prospective new investors to provide the additional cash needed to meet the Company’s obligations as they become due, and will allow the development of its core business. There is no assurance that the Company will be able to continue raising the required capital.

XML

Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2015	Jun. 30, 2015
Condensed Balance Sheets
Amortization of domain	$ 2,540	$ 2,451
Debt discount on convertible promissory notes	$ 260,169	$ 264,196
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred Stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	493,839,853	476,848,072
Common stock, shares outstanding	493,839,853	476,848,072

XML

Derivative Liabilities (Tables)

3 Months Ended

Sep. 30, 2015

Derivative Liabilities [Abstract]

Schedule of share-based payment award, stock options, valuation assumptions

Risk free interest rate	0.00% - 0.47%
Stock volatility factor	15.55% - 318.08%
Weighted average expected option life	1 month - 9 months
Expected dividend yield	None

XML

Document and Entity Information - shares	3 Months Ended
	Sep. 30, 2015	Nov. 05, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	Hypersolar, Inc.
Entity Central Index Key	0001481028
Amendment Flag	false
Trading Symbol	hysr
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Current Fiscal Year End Date	--06-30
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2016
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		510,893,000

XML

Summary of Significant Accounting Policies (Details) - USD ($)	Sep. 30, 2015	Jun. 30, 2015
Liabilities
Derivative Liability	$ 10,803,002
Total liabilities measured at fair value	$ 10,803,002
Fair value measurements on recurring basis [Member] | (Level 1) [Member]
Liabilities
Derivative Liability
Total liabilities measured at fair value
Fair value measurements on recurring basis [Member] | (Level 2) [Member]
Liabilities
Derivative Liability
Total liabilities measured at fair value
Fair value measurements on recurring basis [Member] | (Level 3) [Member]
Liabilities
Derivative Liability	$ 10,803,002	$ 13,034,374
Total liabilities measured at fair value	$ 10,803,002

XML

Statements of Operations - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Statements of Operations
REVENUE
OPERATING EXPENSES
General and administrative expenses	$ 121,997	$ 116,974
Research and development cost	21,735
Depreciation and amortization	257	$ 339
TOTAL OPERATING EXPENSES	143,989	117,313
LOSS FROM OPERATIONS BEFORE OTHER INCOME (EXPENSES)	$ (143,989)	$ (117,313)
OTHER INCOME/(EXPENSES)
Gain on forgiveness of debt
Net Gain/(Loss) on change in derivative liability	$ 2,381,372	$ 2,853,054
Interest expense	(180,140)	(126,486)
TOTAL OTHER INCOME/(EXPENSES)	2,201,232	2,726,568
NET INCOME	$ 2,057,243	$ 2,609,255
BASIC AND DILUTED LOSS PER SHARE	$ 0.00	$ 0.01
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED	477,217,459	443,550,158

XML

Derivative Liabilities

3 Months Ended

Sep. 30, 2015

Derivative Liabilities [Abstract]

DERIVATIVE LIABILITIES

6. DERIVATIVE LIABILITIES

The convertible notes (the “Notes”) issued and described in Note 5 do not have fixed settlement provisions because their conversion prices are not fixed. The conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.

During the three months ended September 30, 2015, as a result of the Notes issued that were accounted for as derivative liabilities, we determined that the fair value of the conversion feature of the convertible notes at issuance was $256,970, based upon a Black-Sholes-Model calculation. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the Notes.

During the three months ended September 30, 2015, approximately $24,500 in principal of the Notes were converted. As a result of the conversion of these Notes, and the change in fair value of the remaining Notes, the Company recorded a net gain in change in derivative of $2,488,342 in the statement of operations for the three months ended September 30, 2015. At September 30, 2015, the fair value of the derivative liability was $10,803,002.

For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivative are as follows:

Risk free interest rate	0.00% - 0.47%
Stock volatility factor	15.55% - 318.08%
Weighted average expected option life	1 month - 9 months
Expected dividend yield	None

XML

Convertible Promissory Notes

3 Months Ended

Sep. 30, 2015

Convertible Promissory Notes [Abstract]

CONVERTIBLE PROMISSORY NOTES

5. CONVERTIBLE PROMISSORY NOTES

On August 9, 2013, the Company entered into a securities purchase agreement entered into for the sale of a 10% convertible promissory note in the aggregate principal amount of up to $100,000. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of a) $0.0048 per share; b) fifty percent (50%) of the lowest trading price after the effective date of each respective advance or c) the lowest conversion price offered by the Company with respect to any financing occurring before or after the date to acquire common stock. Upon execution of the securities purchase agreement, the Company received an advance of $15,000. The Company received additional advances in the aggregate amount of $85,000 for a total aggregate principal sum of $100,000. The Note matured on July 9, 2015, and the maturity date was extended to April 9, 2016. On September 28, 2015, the Company issued 16,991,781 shares of common stock upon conversion of $24,500 in principal, plus accrued interest of $5,236. The remaining balance as of September 30, 2015 was $75,500.

On December 16, 2013, the Company entered into a securities purchase agreement entered for the sale of a 10% convertible promissory note in the aggregate principal amount of up to $100,000. The Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.0048 per share or fifty percent (50%) of the lowest trading price after the effective date to acquire common stock. Upon execution of the securities purchase agreement, the Company received an advance of $26,000. The Company received additional advances in the amount of $74,000 for an aggregate sum of $100,000. The Note matured on May 16, 2015, and the maturity date was extended to February 16, 2016.

On March 5, 2014, the Company entered into a securities purchase agreement into for the sale of a 10% convertible promissory note in the aggregate principal amount of up to $100,000. The Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.0048 per share or fifty percent (50%) of the lowest trading price after the effective date to acquire common stock. Upon execution of the securities purchase agreement, the Company received an advance of $30,000. On April 15, 2014, the lender and borrower agreed to amend the note to increase the principle sum to $150,000. The Company received additional advances in the amount of $120,000 for an aggregate sum of $150,000. The Note matured on September 5, 2015 and was extended to June 5, 2016.

On May 23, 2014, the Company entered into a securities purchase agreement for the sale of a 10% convertible promissory note in the aggregate principal amount of up to $500,000. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.0048 per share or fifty percent (50%) of the lowest trading price after the effective date to acquire common stock. Upon execution of the securities purchase agreement, the Company received an advance of $50,000. The Company received additional advances in the amount of $415,000 for an aggregate sum of $465,000. The Note matured on May 23, 2015 and was extended to February 23, 2016. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $79,397 during the three months ended September 30, 2015.

On April 9, 2015, the Company entered into a securities purchase agreement into for the sale of a 10% convertible promissory note in the aggregate principal amount of up to $500,000. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of each respective advance or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. Upon execution of the securities purchase agreement, the Company received an advance of $50,000. The Company received additional advances in the amount of $250,000 for an aggregate sum of $300,000. The note matures nine (9) months from the effective dates of each respective advance. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $74,630 during the three months ended September 30, 2015.

ASC Topic 815 provides guidance applicable to convertible debt issued by the Company in instances where the number into which the debt can be converted is not fixed. For example, when a convertible debt converts at a discount to market based on the stock price on the date of conversion, ASC Topic 815 requires that the embedded conversion option of the convertible debt be bifurcated from the host contract and recorded at their fair value. In accounting for derivatives under accounting standards, the Company recorded a liability representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount representing the imputed interest associated with the embedded derivative. The discount is amortized over the life of the convertible debt, and the derivative liability is adjusted periodically according to stock price fluctuations.

XML

Stock Options (Details Textuals) - $ / shares	3 Months Ended
	Sep. 30, 2015	Mar. 31, 2015	Jun. 30, 2015
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-qualified stock options to an employee
Non-qualified common stock were outstanding	500,000		500,000
Stock options exercisable	250,000
Exercisable price	$ 0.04
Description of options vesting conditions	Fifty (50%) percent of the options vest on March 31, 2016 and the remaining fifty (50%) on March 31, 2017. These stock options are exercisable for a period of five years from the date of grant at an exercise price of $0.02245 per share.
Non-qualified stock options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-qualified stock options to an employee		250,000
Stock options exercisable period		5 years
Exercisable price		$ 0.02245
Non-qualified common stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-qualified common stock were outstanding		500,000

XML

Summary of Significant Accounting Policies (Details 1)	3 Months Ended
	Sep. 30, 2015 USD ($)
Fair Value, Assets and Liabilities Measured On Recurring and Nonrecurring Basis [Line Items]
Ending balance as of September 30, 2015	$ 10,803,002
Fair Value Measurements [Member]
Fair Value, Assets and Liabilities Measured On Recurring and Nonrecurring Basis [Line Items]
Fair value of derivative liabilities issued	256,970
Gain on change in derivative liability	2,488,342
(Level 3) [Member] | Fair Value Measurements [Member]
Fair Value, Assets and Liabilities Measured On Recurring and Nonrecurring Basis [Line Items]
Beginning balance as of July 1, 2015	13,034,374
Fair value of derivative liabilities issued	256,970
Gain on change in derivative liability	(2,488,342)
Ending balance as of September 30, 2015	$ 10,803,002

XML

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2015

Summary of Significant Accounting Policies [Abstract]

Schedule of measurement of assets and liabilities at fair value on recurring basis

	Total		(Level 1)		(Level 2)		(Level 3)
Liabilities
Derivative liability		10,803,002		-		-		10,803,002
Total liabilities measured at fair value	$	10,803,002	$	-	$	-	$	10,803,002

Summary of reconciliation of the derivative liability

Beginning balance as of July 1, 2015	$	13,034,374
Fair value of derivative liabilities issued		256,970
Gain on change in derivative liability		(2,488,342	)
Ending balance as of September 30, 2015	$	10,803,002

XML

Subsequent Events

3 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

7. SUBSEQUENT EVENTS

Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855, and reported the following events:

On October 1, 2015, the Company received an additional $50,000 advance on the securities purchase agreement entered into on April 9, 2015.

On October 14, 2015, the Company issued 17,053,151 shares of common stock upon conversion of $24,500 in principal, plus accrued interest of $5,343 associated with the securities purchase agreement entered into on August 9, 2013.

On October 21, 2015, the Company received an additional $60,000 advance on the securities purchase agreement entered into on April 9, 2015.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Sep. 30, 2015

Summary of Significant Accounting Policies [Abstract]

Cash and Cash Equivalent

Cash and Cash Equivalent

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of intangible assets, and the deferred tax valuation allowance. Actual results could differ from those estimates.

Intangible Assets

Intangible Assets

Intangible assets consist of patents that are initially measured at the lower of cost or fair value. The patents are deemed to have an indefinite life and are not amortized. The patents are assessed annually for impairment, or whenever conditions indicate the asset may be impaired, and any such impairment will be recognized in the period identified.

Loss per Share Calculations

Loss per Share Calculations

Loss per Share dictates the calculation of basic earnings per share and diluted earnings per share. Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. No shares for the convertible notes were used in the calculation of the loss per share as they were all anti-dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the three months ended September 30, 2015, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company excluded 500,000 of options, and the shares issuable from convertible debt of $1,090,500 for the three months ended September 30, 2015.

Stock based Compensation

Stock based Compensation

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Fair value of financial instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2015, the amounts reported for cash, accrued interest and other expenses, notes payables, and derivative liability approximate the fair value because of their short maturities.

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at September 30, 2015:

	Total		(Level 1)		(Level 2)		(Level 3)
Liabilities
Derivative liability		10,803,002		-		-		10,803,002
Total liabilities measured at fair value	$	10,803,002	$	-	$	-	$	10,803,002

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

Beginning balance as of July 1, 2015	$	13,034,374
Fair value of derivative liabilities issued		256,970
Gain on change in derivative liability		(2,488,342	)
Ending balance as of September 30, 2015	$	10,803,002

Accounting for Derivatives

Accounting for Derivatives

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Black-Scholes-Merton option pricing models to value the derivative instruments at inception and on subsequent valuation dates.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Recently issued pronouncements

Recently issued pronouncements

On August 27, 2014, the Company adopted the amendment to ASU 2014-15 on Presentation of Financial Statements Going Concern (Subtopic 205-40). The amendment provides for guidance to reduce diversity in the timing and content of footnote disclosures. The amendment requires management to assess the Company’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The Company has to define the term of substantial doubt, which has to be evaluated every reporting period including interim periods. Management has to provide principles for considering the mitigating effect of its plan, and disclose when substantial doubt is alleviated as well as when it is not alleviated. The Company is required to assess managements plan for a period of one year after the financial statements are issued (or available to be issued). The amendment is effective for annual periods ending after December 15, 2016. Early adoption is permitted. The Company does not believe the accounting standards currently adopted will have a material effect on the accompanying condensed financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

XML

Stock Options (Tables)

3 Months Ended

Sep. 30, 2015

Stock Option [Abstract]

Schedule of the Company's stock option activity and related information

	9/30/2015
			Weighted
	Number		average
	of		exercise
	Options		price
Outstanding, beginning of period		500,000	$	0.03
Granted		-		-
Exercised		-		-
Forfeited/Expired		-		-
Outstanding, end of period		500,000	$	0.03
Exercisable at the end of period		250,000	$	0.04
Weighted average fair value of options granted during the period			$	-

XML

Capital Stock (Details)	3 Months Ended
	Sep. 30, 2015 USD ($) shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Principal amount of partial convertible promissory note	$ 1,090,500
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock (in shares) | shares	16,991,781
Principal amount of partial convertible promissory note	$ 24,500
Issuance of common stock on payment of accrued interest for convertible notes	$ 5,236

XML

Derivative Liabilities (Details Textual) - USD ($)	3 Months Ended
	Sep. 30, 2015	Jun. 30, 2015
Derivative Liabilities (Textual)
Convertible notes payable	$ 1,090,500
Derivative liability current	10,803,002	$ 13,034,374
Fair Value Measurements [Member]
Derivative Liabilities (Textual)
Fair value of derivative liabilities issued	256,970
Convertible notes payable	24,500
Gain on change in derivative liability	$ 2,488,342

XML

Statements of Shareholders' Equity Deficit - 3 months ended Sep. 30, 2015 - USD ($)	Total	Preferred stock	Common stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance at Jun. 30, 2015	$ (14,034,690)		$ 476,848	$ 5,568,303	$ (20,079,841)
Beginning balance, shares at Jun. 30, 2015			476,848,072
Issuance of common stock for conversion of debt	29,736		$ 16,992	$ 12,744
Issuance of common stock for conversion of debt, shares			16,991,781
Net income	2,057,243				$ 2,057,243
Ending balance (unaudited) at Sep. 30, 2015	$ (11,947,711)		$ 493,840	$ 5,581,047	$ (18,022,598)
Ending balance (unaudited), shares at Sep. 30, 2015			493,839,853

XML

Stock Options

3 Months Ended

Sep. 30, 2015

Stock Option [Abstract]

STOCK OPTIONS

4. STOCK OPTIONS

Options

On March 31, 2015, the Company granted 250,000 non-qualified stock options to an employee. As of March 31, 2015, 500,000 non-qualified common stock options were outstanding. Each option shall be exercisable to the nearest whole share, in installments or otherwise, as the respective agreements may provide. Each Option expires on the date specified in the Option agreement, which date is not later than the fifth (5^th) anniversary from the grant date of the options. As of September 30, 2015, 250,000 options are fully vested and are exercisable at an exercise price $0.04 per share. The 250,000 stock options granted on March 31, 2015 are not currently exercisable and are subject to vesting conditions which provide that fifty (50%) percent of the options vest on March 31, 2016 and the remaining fifty (50%) on March 31, 2017. These stock options are exercisable for a period of five years from the date of grant at an exercise price of $0.02245 per share.

A summary of the Company’s stock option activity and related information follows:

	9/30/2015
			Weighted
	Number		average
	of		exercise
	Options		price
Outstanding, beginning of period		500,000	$	0.03
Granted		-		-
Exercised		-		-
Forfeited/Expired		-		-
Outstanding, end of period		500,000	$	0.03
Exercisable at the end of period		250,000	$	0.04
Weighted average fair value of options granted during the period			$	-

XML

Subsequent Events (Details) - USD ($)			1 Months Ended	3 Months Ended
	Oct. 14, 2015	Oct. 01, 2015	Oct. 21, 2015	Sep. 30, 2015
Subsequent Events (Textuals)
Issuance of stock for conversion of debt				$ 1,090,500
Subsequent Event [Member]
Subsequent Events (Textuals)
Amount of additional advance received		$ 50,000	$ 60,000
Issuance of common stock (in shares)	17,053,151
Issuance of stock for conversion of debt	$ 24,500
Issuance of common stock on payment of accrued interest for convertible notes	$ 5,343

XML

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended
	Sep. 30, 2015	Jun. 30, 2015
Summary of significant accounting policies (Textual)
Issuance of stock for conversion of debt	$ 1,090,500
Stock options [Member]
Summary of significant accounting policies (Textual)
Stock options outstanding	500,000	500,000